Moreover, miR-15a/16–1 inhibition alleviates ischemic brain injury by suppressing IL-6, MCP-1, VCAM-1, and TNF-α [18], and miR-1906 application can ameliorate ischemic injury in experimental stroke by directly modulating the inflammatory initiator TLR4 [19]. The gene discussed is TLR4; the disease is stroke disorder.